Presentations at the 94th European Atherosclerosis Society (EAS) Congress highlight the breadth of evidence for bempedoic acid across a wide range of patient subgroups and background therapies. Real-world data from the MILOS study across multiple European cohorts demonstrate consistent effectiveness and safety profile in routine clinical practice. 1,2,3,4 Analysis from the CLEAR Outcomes trial underscores the impact of bempedoic acid on cardiovascular risks, including stroke and venous thromboem

TOKYO and PALO ALTO, Calif., May 26, 2026 /PRNewswire/ -- bitBiome, a pioneering force in the field of discovery, design and engineering of novel enzymes, proteins, strains, and ingredients, today announced that it has closed an oversubscribed seed extension round. This investment underscores bitBiome's traction and global relevance in the engineering biology and bio-manufacturing landscape. With this investment, bitBiome is poised to accelerate its mission to discover and engineer microbial enz

Accepted ASCO abstracts highlight Mercy's blood-based lung cancer screening and lung nodule triage programs using specimens from the NLST biorepository, which was established to support validation of early detection lung cancer biomarkers WALTHAM, Mass., May 26, 2026 /PRNewswire/ -- Mercy BioAnalytics, Inc., a pioneer in blood-based early cancer detection, today announced that it will present two abstracts at the 2026 ASCO Annual Meeting highlighting results from studies using biospecimens from

STOCKHOLM, May 26, 2026 /PRNewswire/ -- Sobi® (STO: SOBI) today announced results from a new analysis of the pivotal Phase 3 CORE and CORE2 trials, showing Tryngolza® (olezarsen) reduced the relative risk of acute pancreatitis events by 85% (P<0.001) and reduced triglycerides by 66% in patients with severe hypertriglyceridemia (sHTG) after six months.[1] The pooled subgroup analysis, presented as a late breaking abstract at the European Atherosclerosis Society (EAS) 2026 Congress in Athens, Gree

DELRAY BEACH, Fla., May 26, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Veterinary PoC Diagnostics Market is projected to grow from about USD 1.19 billion in 2026 to USD 1.72 billion by 2031, at a CAGR of 7.7%. Browse through 420 market data tables and 65 figures spread across 450 pages and the in-depth TOC on the 'Veterinary PoC Diagnostics Market - Global Forecast to 2031' Veterinary PoC Diagnostics Market Size & Forecast: Market Size Available for Years: 2025–2031 2026 Market S

WFI manufacturing and other capabilities support for pharmaceutical innovation, GLP ‑ 1 therapies, and medical devices. LILLINGTON, N.C., May 26, 2026 /PRNewswire/ -- ILC Dover, an Ingersoll Rand business and world leader in the innovative design and production for biopharmaceutical, pharmaceutical, and medical device markets, recently invested in two new core capabilities—Water for Injection (WFI) quality water and custom chemical solutions. This is a significant expansion that further strength

Built on Atlas AI™, Ask Atlas allows care teams to ask plain-language questions across their own clinical, operational, and billing data, returning structured answers in seconds. HOUSTON, May 26, 2026 /PRNewswire/ -- Octagos today announced the launch of Ask Atlas, a new AI intelligence capability allowing cardiac device clinics to query their own remote monitoring data using natural language. Continue Reading Ask Atlas™ by Octagos Speed Speed Built on Atlas AI, the intelligence layer of the Oc

Cambridge, Mass., May 26, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, and Human Life Foundation Models, Inc. (HLFM), a newly launched company established by Human Longevity, Inc. today announced a multi-million-dollar AI co-development collaboration to build industry's first large-scale foundation models dedicated to human longevity science. As aging populations reshape global labor markets a

Collaborative research explores how breakthrough engineered therapy works, why remission lasts for some patients, and how to extend its benefits NEW YORK, May 26, 2026 /PRNewswire/ -- Today, the Lupus Research Alliance (LRA), the world's largest private funder of lupus research, in collaboration with Genentech, a member of the Roche Group, announced the inaugural recipients of the Lupus Research Alliance-Genentech Award on Immune Resetting Therapies for Lupus (LGA-IRT). The new program aims to d

SAN DIEGO, May 26, 2026 /PRNewswire/ -- The Deerborne Group, a specialized strategy and management consulting firm focused exclusively on the genomics and precision diagnostics industry, today announced that senior leadership will attend the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting, taking place May 29–June 2 in Chicago, Illinois. ASCO 2026 comes at a pivotal time for the oncology diagnostics industry as companies navigate increasing pressure to align scientific innovatio